Krunal Darji – Rangam
View Detailed Executive Profile →Professional Overview
- Krunal Darji co-founded Rangam Pharmaceuticals in June 2012, marking a significant milestone in their career and contributing to the pharmaceutical industry.
- Under Krunal's leadership, Rangam Pharmaceuticals has focused on developing innovative solutions, striving to enhance medication delivery and patient outcomes.
- Krunal played a key role in establishing strategic partnerships with various healthcare organizations, boosting Rangam's presence in the pharmaceutical sector.
- Rangam Pharmaceuticals faced challenges in the competitive market but adjusted strategies over the years to maintain growth and innovation.
- Through various initiatives, Krunal has emphasized the importance of research and development, positioning Rangam as a forward-thinking organization within the industry.
- Krunal has contributed to building a dedicated team of professionals at Rangam, fostering a collaborative environment to drive success.
- Rangam Pharmaceuticals has achieved several regulatory approvals for its products, a testament to the quality and efficacy of their offerings, driven largely by Krunal's vision.
- By promoting sustainability and ethical practices, Krunal has ensured that Rangam Pharmaceuticals aligns with contemporary values in the healthcare field.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| RANGAM PHARMACEUTICALS | Co-Founder | Jun 2012 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Rangam corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Krunal Darji's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Rangam's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)